Literature DB >> 23213007

The inhibition of early stages of HER-2/neu-mediated mammary carcinogenesis by dietary n-3 PUFAs.

Lisa D Yee1, Deepak Agarwal, Thomas J Rosol, Amy Lehman, Min Tian, Jennifer Hatton, Jessica Heestand, Martha A Belury, Steven K Clinton.   

Abstract

SCOPE: We previously demonstrated that lifelong feeding of diets enriched in n-3 fatty acids such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) significantly inhibits HER-2/neu-mediated mammary tumorigenesis in mice. Of interest is whether dietary n-3 fatty acids exert effects at early stages of mammary carcinogenesis. METHODS AND
RESULTS: Seven-week-old female MMTV-HER-2/neu transgenic mice were randomized to AIN-based semipurified diets containing either fish or corn oil at 25% energy. Mice were evaluated at 25, 30, and 35 weeks with analysis of mammary glands for atypical ductal hyperplasia (hematoxylin and eosin), cell proliferation (Ki67 immunostaining), and fatty acid synthase and cyclooxygenase-2 gene expression (qRT-PCR). Tissue fatty acid profiles were quantitated by GC. Atypia grade decreased significantly in mice fed fish oil (p = 0.002). Mammary epithelial cells in mammary glands from mice fed fish oil also had an eightfold lower percentage of Ki67 expression. COX-2 expression in mammary fat-pads significantly decreased in mice fed fish versus corn oil enriched diets.
CONCLUSION: Dietary fish oil inhibits atypical ductal hyperplasia at early stages of HER-2/neu-mediated mammary carcinogenesis relative to corn oil diets. This histologic change is associated with suppression of mammary epithelial cell proliferation and decreased COX-2 expression in mammary tissue.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23213007      PMCID: PMC3855004          DOI: 10.1002/mnfr.201200445

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  36 in total

1.  Intermediate endpoints of primary systemic therapy in breast cancer patients.

Authors:  Alfredo Berruti; Daniele Generali; Valentina Bertaglia; Maria Pia Brizzi; Teresa Mele; Luigi Dogliotti; Paolo Bruzzi; Alberto Bottini
Journal:  J Natl Cancer Inst Monogr       Date:  2011

2.  Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition.

Authors:  Lisa D Yee; Joanne L Lester; Rachel M Cole; Julia R Richardson; Jason C Hsu; Yan Li; Amy Lehman; Martha A Belury; Steven K Clinton
Journal:  Am J Clin Nutr       Date:  2010-03-24       Impact factor: 7.045

3.  Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.

Authors:  M J van de Vijver; J L Peterse; W J Mooi; P Wisman; J Lomans; O Dalesio; R Nusse
Journal:  N Engl J Med       Date:  1988-11-10       Impact factor: 91.245

4.  NTP Toxicology and Carcinogenesis Studies of t-Butylhydroquinone (CAS No. 1948-33-0) in F344/N Rats and B6C3F(1) Mice (Feed Studies).

Authors: 
Journal:  Natl Toxicol Program Tech Rep Ser       Date:  1997-05

5.  Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3.

Authors:  Kotha Subbaramaiah; Larry Norton; William Gerald; Andrew J Dannenberg
Journal:  J Biol Chem       Date:  2002-03-18       Impact factor: 5.157

6.  HER2 regulation of peroxisome proliferator-activated receptor gamma (PPARgamma) expression and sensitivity of breast cancer cells to PPARgamma ligand therapy.

Authors:  Zhibo Yang; Rozita Bagheri-Yarmand; Seetharaman Balasenthil; Gabriel Hortobagyi; Aysegul A Sahin; Christopher J Barnes; Rakesh Kumar
Journal:  Clin Cancer Res       Date:  2003-08-01       Impact factor: 12.531

7.  Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells.

Authors:  Javier A Menendez; Luciano Vellon; Inderjit Mehmi; Bharvi P Oza; Santiago Ropero; Ramon Colomer; Ruth Lupu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-02       Impact factor: 11.205

8.  Regulation of HER-2 oncogene expression by cyclooxygenase-2 and prostaglandin E2.

Authors:  Valérie Benoit; Biserka Relic; Xavier de Leval Xd; Alain Chariot; Marie-Paule Merville; Vincent Bours
Journal:  Oncogene       Date:  2004-02-26       Impact factor: 9.867

9.  Reduction of leptin gene expression by dietary polyunsaturated fatty acids.

Authors:  J E Reseland; F Haugen; K Hollung; K Solvoll; B Halvorsen; I R Brude; M S Nenseter; E N Christiansen; C A Drevon
Journal:  J Lipid Res       Date:  2001-05       Impact factor: 5.922

10.  Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment.

Authors:  Peter A Fasching; Katharina Heusinger; Lothar Haeberle; Melitta Niklos; Alexander Hein; Christian M Bayer; Claudia Rauh; Ruediger Schulz-Wendtland; Mayada R Bani; Michael Schrauder; Laura Kahmann; Michael P Lux; Johanna D Strehl; Arndt Hartmann; Arno Dimmler; Matthias W Beckmann; David L Wachter
Journal:  BMC Cancer       Date:  2011-11-14       Impact factor: 4.430

View more
  16 in total

1.  Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Postmenopausal Women.

Authors:  Carol J Fabian; Bruce F Kimler; Teresa A Phillips; Jennifer L Nydegger; Amy L Kreutzjans; Susan E Carlson; Brandon H Hidaka; Trina Metheny; Carola M Zalles; Gordon B Mills; Kandy R Powers; Debra K Sullivan; Brian K Petroff; Whitney L Hensing; Brooke L Fridley; Stephen D Hursting
Journal:  Cancer Prev Res (Phila)       Date:  2015-08-14

2.  Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Premenopausal Women.

Authors:  Carol J Fabian; Bruce F Kimler; Teresa A Phillips; Jessica A Box; Amy L Kreutzjans; Susan E Carlson; Brandon H Hidaka; Trina Metheny; Carola M Zalles; Gordon B Mills; Kandy R Powers; Debra K Sullivan; Brian K Petroff; Whitney L Hensing; Brooke L Fridley; Stephen D Hursting
Journal:  Cancer Prev Res (Phila)       Date:  2015-10

3.  Long-Chain Omega-3 Polyunsaturated Fatty Acids Modulate Mammary Gland Composition and Inflammation.

Authors:  Saraswoti Khadge; Geoffrey M Thiele; John Graham Sharp; Timothy R McGuire; Lynell W Klassen; Paul N Black; Concetta C DiRusso; James E Talmadge
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-03-25       Impact factor: 2.673

Review 4.  The effects of omega-3 polyunsaturated Fatty Acid consumption on mammary carcinogenesis.

Authors:  Theodore R Witte; W Elaine Hardman
Journal:  Lipids       Date:  2015-04-10       Impact factor: 1.880

Review 5.  ER stress and impaired autophagy flux in neuronal degeneration and brain injury.

Authors:  Yan Yin; George Sun; Eric Li; Kirill Kiselyov; Dandan Sun
Journal:  Ageing Res Rev       Date:  2016-09-01       Impact factor: 10.895

6.  Long-chain omega-3 polyunsaturated fatty acids decrease mammary tumor growth, multiorgan metastasis and enhance survival.

Authors:  Saraswoti Khadge; Geoffrey M Thiele; John Graham Sharp; Timothy R McGuire; Lynell W Klassen; Paul N Black; Concetta C DiRusso; Leah Cook; James E Talmadge
Journal:  Clin Exp Metastasis       Date:  2018-10-16       Impact factor: 5.150

7.  Incorporation of eicosapentaenioic and docosahexaenoic acids into breast adipose tissue of women at high risk of breast cancer: a randomized clinical trial of dietary fish and n-3 fatty acid capsules.

Authors:  Shana Straka; Joanne L Lester; Rachel M Cole; Rebecca R Andridge; Sarah Puchala; Angela M Rose; Steven K Clinton; Martha A Belury; Lisa D Yee
Journal:  Mol Nutr Food Res       Date:  2015-07-07       Impact factor: 5.914

Review 8.  Omega-3 fatty acids for breast cancer prevention and survivorship.

Authors:  Carol J Fabian; Bruce F Kimler; Stephen D Hursting
Journal:  Breast Cancer Res       Date:  2015-05-04       Impact factor: 6.466

9.  Change in Blood and Benign Breast Biomarkers in Women Undergoing a Weight-Loss Intervention Randomized to High-Dose ω-3 Fatty Acids versus Placebo.

Authors:  Carol J Fabian; Christie A Befort; Teresa A Phillips; Jennifer L Nydegger; Amy L Kreutzjans; Kandy R Powers; Trina Metheny; Jennifer R Klemp; Susan E Carlson; Debra K Sullivan; Carola M Zalles; Erin D Giles; Stephen D Hursting; Jinxiang Hu; Bruce F Kimler
Journal:  Cancer Prev Res (Phila)       Date:  2021-07-09

10.  Mammary tumour development is dose-dependently inhibited by n-3 polyunsaturated fatty acids in the MMTV-neu(ndl)-YD5 transgenic mouse model.

Authors:  Michael A Leslie; Salma A Abdelmagid; Kate Perez; William J Muller; David Wl Ma
Journal:  Lipids Health Dis       Date:  2014-06-11       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.